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ABSTRACT 
“CLINICAL PROFILE AND OUTCOME IN PATIENTS WITH COMMUNITY ACQUIRED 
PNEUMONIA.” 
By 
Dr. Hardik Manubhai Pipalia 
Introduction - Community-acquired pneumonia (CAP) is one of the most common infectious 
diseases addressed by clinicians and is an important cause of mortality and morbidity 
worldwide. Pneumonia is one of the leading causes of death and morbidity, both in 
developing and developed countries and is the commonest cause (10%) of hospitalization in 
adult and children. Estimates of the incidence of community-acquired pneumonia range 
from 4 million to 5 million cases per year, with about 25% requiring hospitalization. 
Community-acquired pneumonia refers to pneumonia acquired outside of hospitals or 
extended-care facilities. The objective of the project to study etiological profile, clinical and 
radiological profile and hospital outcome, the applicability of PSI score for the outcome, the 
outcome related to age, gender, and risk factors in patients with CAP. 
Method – The data was primarily collected in the department of medicine who were 
diagnosed as community acquired pneumonia at GCS medical college, Ahmedabad, India 
during 2014 to 2015. It is a retrospective clinical observational study which includes 50 adult 
patients with CAP at admission to the hospital. Detailed relevant history and clinical 
examination were done according to predesign and pre-tested format. The patients were 
classified according to PSI score classification. The collected data was analyzed and 
compared with previous studies on same/similar topics. Statistical analysis like chi square 
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test, mean, standard deviation of the mean, and Fischer exact test were done. 
Result – In this study, 48% patients were with bacteriological pneumonia, and 38% were 
H1N1 pneumonia. Among those patients, risk factors for CAP like upper respiratory tract 
infection (24%), Lung pathology (14%), Smoking (24%), and Diabetes mellitus (14%) were 
present and statistically significant(p<0.05). Also, a radiological profile like lobar pneumonia 
was most common in bacterial pneumonia (75%), and bronchopneumonia was most 
common in H1N1 pneumonia (52.6%) which found statistically significant (p<0.05) in the 
research study. In this study, death had occurred in 8.33% bacterial pneumonia, and 36.8% 
H1N1 pneumonia which was statistically significant as p value is <0.05 by chi square test. In 
the present study, 50% patients in PSI class IV and class V died which was statistically 
significant (p<0.05), 100% patients of class V and 87.5% patients of class IV developed 
complications, and most common complication was respiratory failure (47.3%) in H1N1 
pneumonia, and most common complication was pleural effusion (20.8%) in bacterial 
pneumonia.  
Conclusion – In present study, H1N1 is most common pathogen (38%) in CAP followed by 
Streptococcus pneumonia (28%) and death due to CAP was higher in H1N1(36.8%) in 
compare to bacterial cause (8.33%) because this study’s data was taken in September 2014 
to September 2015 which was the time of H1N1 epidemic in that region of India. In the 
present study, most common chest x ray finding was patchy consolidation followed by left 
lower zone involvement and right lower zone involvement. PSI (pneumonia severity index) 
score is used for determination of hospital admission and assess 30-days mortality. Clinical 
trials demonstrate that routine use of the PSI score results in lower admission rates for a 
class I and class II patients. Patients in class III could ideally be admitted to an observation 
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unit until a further decision can be made. In the present study, mortality was 50% in class IV 
and class V patients.  
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CHAPTER 1 
INTRODUCTION 
Background 
Pneumonia is a disease known to humanity from antiquity. Pneumonia is an acute 
inflammation of the pulmonary parenchyma that can be caused by various infective and 
noninfective origins, presenting with physical and radiological features compatible with the 
pulmonary consolidation of a part or parts of one or both lungs (Seaton, Seaton, Leitch, & Crofton, 
2000). 
 Pneumonia signifies a pulmonary inflammatory process. The most significant and striking 
feature of which is consolidation (Kasper et al., 2005). Community acquired pneumonia is an acute 
illness acquired in the community with symptoms suggestive of LRTI. Together with the presence of 
a chest radiograph of intra-pulmonary shadowing which is likely to be new and has no clear 
alternative cause (Seaton, Seaton, Leitch, & Crofton, 2000). Pneumonia is one of the leading causes 
of death and morbidity, both in developing and developed countries and is the commonest cause 
(10%) of hospitalization in adult and children (Hall et al., 20011). 
Increasingly newer microbiological agents some of which are well known and some are very 
new pathogens has revolutionized the understanding of pneumonia, and this led to the extensive 
use of modern antibiotics (J. Bartlett, 2000). In the late twentieth and twenty-first century, newer 
microbial agents have emerged like - opportunistic lung infection in patients with HIV infection and 
post organ transplant patients (J. Bartlett, 2000).  All these have led to the need for an 
understanding of the immunological status of the individual. With the beginning of an antibiotic era, 
the mortality rate leveled off and remained constant. This mortality rate is heavily weighted against 
elderly. This predilection of pneumonia for elderly is not new and led William Osler in 1898 to 
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describe as ‘friend of the aged' J. (G. Bartlett et al., 2000). The actual incidence of pneumonia 
acquired in the community is unknown and undoubtedly primary care physicians treat many 
pneumonia episodes as ‘lower respiratory tract infection’ or ‘bronchiolitis’ without recourse to chest 
radiographs (Stocks, Turnidge, & Crockett, 2004). 
Gap and Purpose of the study 
Previously, H1N1 pandemic 2009 and post pandemic 2014 has led to a massive interest in 
H1N1 pneumonia. However clinical profile and outcome in CAP from varied etiology in a various 
group of patients remain under documented and requires comprehensive study. Several prospective 
studies have shown that risk factors for community acquired pneumonia are COPD, diabetes 
mellitus, renal insufficiency, congestive cardiac failure, coronary artery disease, malignancy, chronic 
neurologic disease, chronic liver disease, alcoholism, and smoking (Shah, Giudice, Griesback, Morley, 
& Vasoya, 2004). There is a lack of scientific research in our population about PSI score as the 
prognostic score for outcome in CAP. This study attempts to use PSI score as prognostic markers for 
in hospital outcome in CAP. The purpose of undertaking this study is to study clinical profile, 
complication, and outcome in CAP of varied etiology.  
AIMS AND OBJECTIVES 
● To study Etiological profile in CAP 
● To Study of clinical profile, radiological profile, in hospital outcome in CAP of different 
etiology. 
● To study the outcome of CAP patients related to age and gender. 
● To study the applicability of PSI score for in hospital outcome in CAP. 
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CHAPTER 2 
REVIEW OF LITERATURE 
Epidemiology of CAP 
John G. Barlett and Linda M. Mundy studied that, “the elderly patients who constitute the 
adult population group with highest attack rate for CAP & the group with the highest mortality due 
to disease” (J. Bartlett, 2000). M. J. Fine and others concluded their study that, “the mortality for 
patients hospitalized with CAP was high and was associated with characteristics of the cohort, 
pneumonia etiology, and a variety of prognostic factors” (M. J. Fine et al., 1996, 1997). According to 
the Bartlett JG et all, “In the United States, approximately 4 million cases of pneumonia occur each 
year, accounting for 10 million physician visits, approximately 500,000 hospitalizations, and 
approximately 45,000 deaths” (Bartlett, Breiman, Mandell, & File, 1998). While the mortality has 
ranged from 2% to 30% among hospitalized patients, the average rate is approximately 14% (Bartlett 
et al., 1998). According to Mandell LL, “Mortality is estimated to be less than 1% for patients who are 
not hospitalized. The total estimated cost of treating CAP is $23 billion, with indirect costs (e.g., 
absence from work) accounting for a significant percentage of this amount” (Mandell, 1995). For 
persons between the ages of 5-60 years, various studies have reported the incidence of CAP 
between 100-500 per 100,000 population (Mandell, 1995). According to Houston MS, et al., “CAP 
occurs more commonly in children younger than the age of 5 years and adults older than the age of 
65 years. In 1987, Houston and colleagues retrospectively evaluated the incidence of pneumonia 
(nursing home and community-associated) in elderly residents (> 65 years of age) in Homestead 
County, Minneapolis, MN” (Millett, Quint, Smeeth, Daniel, & Thomas, 2013).   
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Summary of Literature Review 
This review discusses the predisposing factors, causative pathogens, pathogenesis, etiology, as well 
as the diagnostic studies and antimicrobial management of this important infection.  
Dey at al shown that the presence of certain factors in addition to old age like h/o smoking 
presence of COPD, late presentation to hospital, systolic & diastolic hypotension, high blood urea, 
low serum albumin and development of septic shock was associated with higher incidence of 
complications and a poorer prognosis (Dey, Nagarkar, & Kumar, 1997). 
Marrie and her team recently summarized the findings from nine such studies that 
streptococcus pneumoniae was the most common pathogen, accounting for 9% to 55% of cases in 
the various studies or 18% of the pooled data from all studies and streptococcus pneumoniae 
remains the most important pathogen; however, emerging resistance of the organism to 
antimicrobial agents has affected empirical treatment of CAP (Mandell, Marrie, Grossman, Chow, & 
Hyland, 2000). Diagnostic evaluation of CAP is essential for the appropriate assessment of severity of 
illness and establishment of the causative agent of the disease (Garibaldi, 1985). According to 
Michael J. Fine et al., they found a prediction rule to identify low-risk patients with community-
acquired pneumonia. This prediction rule may help physicians to make more rational decisions about 
hospitalization with pneumonia (Michael J. Fine et al., 1997). According to T. Franquet, has shown 
that when an infectious pulmonary process is suspected, knowledge of varied radiographic 
manifestations will narrow the differential diagnosis, helping to direct additional diagnostic 
measures, and serving an ideal tool for follow up examination (Franquet, 2001). Joshua P. Metlay, 
Michael J. Fine  have reviewed the test characteristics of the history, physical examination, and 
laboratory findings, individually and in combination in the diagnosis Of CAP and predicted the short-
term risk of death from the infection and shown that the absence of vital sign abnormalities 
substantially reduces the possibility of the infection (Joshua P. Metlay & Fine, 2003). Jose Vilar and 
others revealed in their study that the role of the radiologist is to be decisive in their diagnosis and 
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follow up. The CXR remains a basic tool for this purpose (Vilar, Domingo, Soto, & Cogollos, 2004). 
Sanraj K. Basi and others have studied that 1/3rd of patients suspected having pneumonia and is 
admitted to hospital did not have pneumonia, but had serious LRTI with substantial rates of 
bacteremia and mortality. The absence of radiographic findings should not supersede clinical 
judgment and empiric treatments in these patients (Basi, Marrie, Huang, & Majumdar, 2004). J. P. 
Metlay and others concluded in their study that respiratory, and non-respiratory symptoms are less 
commonly reported by older patients with pneumonia even after the control, increased comorbidity, 
and illness severity in these older patients (J. P. Metlay, Schulz, et al., 1997). Larry G. Reimer and 
Karen C. Carrol found that ‘maximum benefit from currently available tests can be derived by their 
use in patients with clear clinical and radiographic evidence of pneumonia' (Reimer & Carroll, 1998). 
Robert E. Siege and others have concluded in their study that adult patients hospitalized for 
CAP who are not severely ill can be successfully treated with an abbreviated (2 day) course of iv 
antibiotics and then switched over to oral therapy (Siegel et al., 1996). A longer course of iv therapy 
prolongs hospital stay and cost, without improving the therapeutic cure rate (Siegel et al., 1996). 
Roger G. et al.  studied that ‘CAP’ is a common condition, which has a significant mortality. The 
management is centered around assessment and correction of gas exchange and fluid balance 
together with administration of appropriate antibiotics’ (Roger et al.,1998). Thomas M. File Jr. 
reviewed important features and management issues of CAP that were particularly relevant to 
immunocompetent adults considering new information about the cause, clinical course, diagnostic 
testing, treatment, and prevention (File, 2003).  
Thomas P. et al. studied that pneumonia is a frequent cause of hospitalization and death 
among elderly patients, but the relationship between processes of care for pneumonia and 
outcomes are uncertain, making quality improvement a challenge (Meehan, Fine, Krumholz, & et al., 
1997). 
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CHAPTER 3 
Introduction 
HISTORICAL REVIEW 
Community acquired pneumonia has been recognized as a common and potentially 
lethal condition for nearly two centuries. The term pneumonia (peri pneumonia) was first 
introduced by Hippocrates in fourth century BC at that time treatment included leeches, 
couplings, and shapes applied to the chest wall together with emetics, tonics, and purges to the 
inflammation away from the chest. Vigorous bloodletting was also popular, particularly in 
Great Britain. The erroneous concepts of anatomy and physiology of lung, which prevailed up 
to last century, hampered the real understanding of pneumonia although it was regarded as 
some inflammation of the lung. Celsus and others accurately described the condition. 
Morgagni (1682-1717) identified the clinical features of pneumonia- solidification of 
lungs. Gallon Carl Rokintasky (1804-1875) was first to differentiate between lobar pneumonia 
and bronchopneumonia. William Wood Gerhard (1809-1872) wrote interesting papers on 
smallpox and pneumonia in children. In 1834 Laennec paved the way for a modern 
understanding of lobar pneumonia by describing the three stages of consolidation, 
pathologically. PITIUS RATTLE (CRACKLES) as a pathognomonic sign of the first stage of 
pneumonia., and is still considered. William Macullum (1874) demonstrated pathological 
features of pneumonia. In 1879, a Swiss Physician described seven causes of atypical 
pneumonia after contact with tropical birds. In 1881, Pasteur and Sternberg demonstrated 
pneumococcus from normal saliva. Towards the end of nineteenth-century causes of 
pneumonia became a matter of hot debate. Friedlander (1881-1884) first found bacteria in the 
lungs of fatal causes of pneumonia, using staining technologies perfected by his colleague gram 
and isolated an organism called pnemoneikrococcus (Friedlander's bacilli) from 30-year-old 
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man died of pneumonia. 
Several years later, Frinkel and others identified serological types of pneumonia, 
which eventually led to serum therapy. With the discovery of penicillin (1951) and other 
antibiotics, the solution to pneumonia was apparently sought, and interest in pneumonia 
waned. Then it was found that there were ‘atypical pneumonia,' which is less severe and did 
not respond to penicillin therapy (e.g. Mycoplasma pneumonia-eaton agent, Coxiella Burnetti- 
Q fever, chlamydia psittacocci-psittacosis). Later in 1957 by the immunofluorescent technique, 
they demonstrated a species of mycoplasma in the bronchial epithelium. Next major event in 
the history of pneumonia was the outbreak of legionnaires disease in Philadelphia in 1976. 
With many advances in the discovery of microbiological etiology of pneumonia, and modern 
antibiotics have revolutionized the understanding and treatment of pneumonia. In late 20th 
century, newer microbiological agents (opportunistic infections) in immunosuppressed patients 
have been increasingly recognized, and this led to the need for an understanding of the 
immunological status of the individual with pneumonia. 
The most recent event occurred in 1986, does chlamydia pneumonia cause 
pneumonia. This species is different from psittacosis. Although the bacteriological diagnosis 
and immunological status of the individual have explained the pathophysiology of pneumonia, 
the radiological recognition continues to be the most valuable investigative tool for the 
diagnosis of pneumonia. The radiological type of pneumonia does give a major clue regarding 
etiology and clinical outcome of pneumonia. Hence this attempt, to define and establish 
completely the clinical, bacteriological, and radiological profile of pneumonia acquired in the 
community admitted in our hospitals. 
Community Acquired Pneumonia (CAP) 
CAP is a common condition, which is caused by a variety of microbial pathogens with 
differing antibiotic sensitivities. It presents as a spectrum of disease ranging from a simple febrile 
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respiratory infection to a severe and fulminating illness leading to death (Finch & Woodhead, 1998). 
An acute illness acquired in the community with symptoms suggestive of a lower respiratory tract 
infection like Fever, cough, sputum-which may be purulent, chest pain, dyspnea together with the 
presence on a chest radiograph of intrapulmonary shadowing which is likely to be new and has no 
clear alternative cause like Lung cancer, pulmonary edema (Niederman et al., 2001). 
Definition of CAP 
A syndrome resulting from acute infection, usually bacterial, characterized by clinical and 
radiographic signs of consolidation of a part or parts of one lung or both lungs (Niederman et al., 
2001). 
Mode of transmission 
Pathogens may enter the lung by following routes like Aspiration of organisms that colonize 
the oropharynx, Inhalation of infectious aerosols, Hematogenous dissemination from an 
extrapulmonary site, Direct inoculation and contiguous (adjoining) spread (Finch & Woodhead, 
1998). 
Pathology 
The pneumonic process may involve the interstitial or alveoli primarily. The involvement of 
an entire lobe is called-lobar pneumonia (Carroll, 2002). When the process is restricted to alveoli 
adjoining to bronchi is called-bronchopneumonia (Carroll, 2002). Cavities develop when necrotized 
lung tissue is discharged into communicating airways (Carroll, 2002). Pathogenesis of pneumonia 
due to various microorganisms is same, but few differences or changes can be seen either in 
pathology or subsequent complication(Carroll, 2002). According to Carroll and team, following is the 
pathological staging for lung: 
Pathological staging  
● Stage of congestion-fine crackles (INDUX CREPITUS) 
● Stage of red hepatisation-tubular bronchial breathing 
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● Stage of grey-hepatisation- tubular bronchial breathing 
● Stage of resolution-coarse crackles (REDUX CREPITUS) 
The gross anatomic alteration may follow from the microscopic changes mentioned. Lobar 
pneumonia may involve one lobe or several lobes, bilateral or unilateral (J. G. Bartlett et al., 2000). 
Widespread involvement of all lobes is not common for the fact that the life can rarely be sustained 
with such total impairment of lung function (J. G. Bartlett et al., 2000). Clinically one entire lobe is 
involved, and inflammation is sharply limited to it by inter lobar fissure (J. G. Bartlett et al., 2000). 
Pneumonia is predisposed by any condition that reduces or suppresses a cough, impairs mucociliary 
activity, reduces the effective phagocytic activity of alveolar macrophages and neutrophils, impairs 
immunoglobulin production (Bhatty, Pruett, Swiatlo, & Nanduri, 2011). 
Etiology 
According to Macfartane et al., Microbial pathogens that cause Community acquired pneumonia is 
following: (Macfarlane, Ward, Finch, & Macrae, 1982) 
A. Infective cause 
                           Bacterial agents 
• Pneumococcal Pneumoniae 
• Staphylococcal Pneumoniae 
• Klebsiella Pneumoniae 
• Pseudomonas Pneumoniae 
• Escherichia Pneumoniae 
• Haemophilus Influenzae Pneumoniae 
• Moraxella Catarrhalis Pneumoniae 
• Legionella Pneumoniae 
• Mycoplasma Pneumoniae 
• Chlamydia Pneumoniae 
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 Viral agents 
• Influenza, Cytomegalovirus 
• Respiratory Synctial Virus 
• Measles 
• Hanta Virus 
 Other agents - Histoplasma, Coccidiodes, Blastomycoces, Parasitic Pneumonia 
B. Non-Infective Cause - Lipid Physical Pneumonia, Radiation Pneumonia 
Classification of pneumonia 
According to Barlett et al., There are different classification based on studies which described below 
(Barlett, Boitano, & Barman, 2010) 
1. Morbid anatomist’s classification 
1.Lobar pneumonia 
2.Segmental pneumonia 
3.Sub segmental pneumonia 
4.Bronchopneumonia 
2. Empiricist’s classification 
1. Community acquired pneumonia 
2. Hospital acquired pneumonia 
3. Aspiration pneumonia 
4. Immunocompromised pneumonia-aids related 
3. Microbiologist’s classification 
1. Bacterial 
2. Viral 
3. Bacteria like and rickettsia like pneumonia 
4. Fungal 
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5. Parasitic pneumonia 
6. Chemical pneumonia 
7. Physical pneumonia-ionizing pneumonia 
4. Behaviorist’s classification 
1. Easy pneumonia 
2. Difficult pneumonia 
The widely accepted classification of pneumonia is based on causative organism rather than 
anatomic characteristics. There are many conditions, which can mimic non-resolving pneumonia. 
They are Hypersensitivity pneumonitis, Drug induced pneumonitis, Sarcoidosis, Systemic necrotizing 
vasculitis, Wagener’s granulomatosis, Pulmonary alveolar prognosis, Neoplastic disorder, and 
Pulmonary embolism (Black, 2016). When a lung lesion diagnosed as pneumonia and fails to respond 
to therapy or the resolution is inappropriately slow (failure of chest x-ray to clear within four weeks, 
then the term non- resolving pneumonia come to play (Black, 2016). The presence of co- morbid 
conditions such as CCF, systemic immunologic diseases, challenges the physician to speculate 
whether these host factors are delaying resolution or to reconsider the diagnosis of pneumonia. 
Furthermore, the severity of pneumonia and responsible pathogen may contribute to the overall 
time required for complete resolution (Finch & Woodhead, 1998). Fein and Fein silver have defined 
pneumonia to be non-resolving when a radiographic infiltrate has failed to resolve in appropriate 
time course for the presumptive diagnosis after at least ten days of antibiotic therapy. Kirtland and 
wlinterbaver described slowly resolving pneumonia as less than 50% clearing of radiographic 
infiltrates at two weeks or less than complete clearing at four weeks in an immunocompetent 
patient who has improved symptomatically. 
Clinical manifestations 
According to Sanraj Basi et al., CAP traditionally presents in two forms (Basi, Marrie, Huang, & 
Majumdar, 2004): 
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 Typical - The typical pneumonia syndrome is characterized by sudden onset of fever 
with or without chills, cough productive of purulent sputum, shortness of breath, pleuritic chest 
pain, haemoptysis, and signs of pulmonary consolidation like dullness, increased vf/vr, egophony, 
bronchial breath sounds and rales may be found on physical examination in chest x-ray. Most 
common pathogen in CAP is Streptococcus Pneumoniae, but can also be due to H. influenzae and 
mixed anaerobic and aerobic components of oral flora (Basi, Marrie, Huang, & Majumdar, 2004). 
 Atypical - The atypical pneumonia is characterized by gradual onset of fever, dry 
cough, shortness of breath, a prominence of extrapulmonary symptoms-headache, myalgia, fatigue, 
sore throat, nausea, vomiting, and diarrhea, with minimal signs on chest x-ray. Atypical pneumonia is 
classically produced by M. pneumoniae, can also be caused by chlamydia pneumoniae, oral 
anaerobes, and Pneumocystis carinii and less frequently encountered pathogens ch.psittaci, Coxiella 
burnetii, Francisella tularensis, H. capsulatum, Coccidioides immitis, and certain viruses also produce 
atypical pneumonia (Basi, Marrie, Huang, & Majumdar, 2004). 
Non-respiratory symptoms of cap include lower lobe pneumonia may present with 
abdominal pain, rigidity, ileus, marked confusion seen in patients with severe pneumonia, 
may present with signs of meningitis, cerebellar dysfunction, evidence of hypoxia, and 
metabolic disturbances (Basi, Marrie, Huang, & Majumdar, 2004). 
Diagnosis 
The patient’s living circumstances, occupation, travel history, animal exposure history and contact 
with patients will provide a clue to the microbial etiology of pneumonia (Joshua P. Metlay & Fine, 
2003). 
According to Joshua et al., Investigation required is following: 
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A. Non-specific- Urine routine, Complete hemogram, Serologic studies-ELISA for HIV-1 and HIV-2, 
Cardiac evaluation-ECG, Blood gas analysis, and Blood culture. 
B. Specific 
1. Non-invasive -  CXR, Sputum examination – AFB and Gram stain, Sputum culture 
2. Invasive – Bronchoscopy, Lung biopsy, and Pleural fluid examination 
Microbiological investigation of patients admitted to the hospital with community acquired 
pneumonia following flowchart (Woodhead, 1991) 
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Treatment 
CAP can be treated as Outpatient or In-Patient depending on the severity of CAP. An 
empirical orally administered antimicrobial approach for mild pneumonia treated in CAP is below 
described according to its category (Michael J. Fine et al., 1997).  
 
Supportive treatment 
The supportive treatment in CAP includes respiratory support given to the patients 
who are in obvious respiratory distress with tachypnea and at a risk of dying due to hypoxia 
and in need of close monitoring (Mandell, Marrie, Grossman, Chow, & Hyland, 2000). A PaO2 
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of 6.7 kpa (50 mmHg) or less in the presence of a rising pco2 and acidosis are clear 
indications that mechanical ventilation may be necessary. Also, Fluid and electrolyte 
replacement gave to the patients with severe pneumonia because they may become 
dehydrated and because of that their depleted intravascular volume requires parenteral 
replacement (Mandell, Marrie, Grossman, Chow, & Hyland, 2000). Total parenteral nutrition 
is best instituted early in cases of pneumonia in whom mechanical ventilation is likely to be 
prolonged. Another consideration like the pleuritic pain is usually easily relieved by giving 
simple non-sedative analgesics. Also, Physiotherapy may assist expectoration of sputum in 
less ill patients (Mandell, Marrie, Grossman, Chow, & Hyland, 2000). 
Complications 
 According to Mbata and his research team mentioned in their article, following are 
the complications of CAP (Mbata, 2013) 
Local General 
Delayed resolution and lung organization Skin rashes 
Spread to other lobes Meningitis, peritonitis, septic 
Lung-abscess - common in Klebsiellosis Arthritis 
Respiratory failure Gastroenteritis 
Pleural effusion, empyema, pneumothorax Hemolytic anemia, 
thrombocytopenia 
Circulatory failure - Pericarditis, myocarditis  
 
Factors associated with high mortality and requiring hospitalization 
 Many researchers found out that adverse prognostic indicators are old age, tachypnoea 
(RR>30/min), hypotension (diastolic<60 mm hg), extensive involvement (>one lobe), atrial 
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fibrillation, initial normal leukocyte count, persistent leukocytosis (> 20,000/pl), leucopenia 
(<500/pl), and Hypoxemia help to check the severity of CAP (Michael J. Fine et al., 1997). 
Following are the factors associated with high mortality and requiring hospitalization (Michael J. 
Fine et al., 1997): 
Clinical Laboratory 
Age> 60 years TC < 4000 or > 20,000/cumm 
RR > 30/min Lymphocytes < 1000/cumm 
HR>140/min Urine output < 20 ml/day 
BP < 90/60 mmHg Chest x-ray biliary involvement 
Altered sensorium PaO2< 60mmHg 
Immunocompromised state Bacteremia 
Differential diagnosis 
 There are many differential diagnoses like Pulmonary tuberculosis, Bronchiectasis, Lung 
abscess, Liver abscess, and Hospital acquired pneumonia. Many studies concluded differences like 
the route of infection, the infective organism, the mode of infection, the rate of mortality, and the 
prevention modalities between CAP and Hospital acquired pneumonia (Niederman, McCombs, 
Unger, Kumar, & Popovian, 1998). 
Pneumonia severity index 
According to Fine et al., “PSI is important prognostic factors in patients who are admitted to 
the hospital. The pneumonia severity index (PSI) or PORT Score is a clinical prediction rule 
that medical practitioners can use to calculate the probability of morbidity and mortality among 
patients with community acquired pneumonia” (Fine et al., 1997). Community-acquired pneumonia 
(CAP) is well known to be one of the leading causes of morbidity and mortality with a significant 
financial burden (Marston et al., 1997).  To manage the challenges of maintaining care quality while 
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limiting treatment costs, many investigators have turned to the development of prognostic scores 
(Ewig et al., 1998). The most widely accepted is the pneumonia severity index (PSI) developed by 
Fine et al. (4), which uses a combination of age and clinical, laboratory and radiographic features to 
estimate the mortality for an episode of CAP (Fine et al., 1997). Following is the PSI table and use 
most of the time to diagnose the severity of CAP (Fine et al., 1997): 
Step 1: Stratify to Risk Class I vs. Risk Classes II-V 
 Presence of: 
  Over 50 years of age Yes/No 
  Altered mental status Yes/No 
  Pulse ≥125/minute Yes/No 
  Respiratory rate >30/minute Yes/No 
  Systolic blood pressure <90 mm Hg Yes/No 
  Temperature <35°C or ≥40°C Yes/No 
 History of: 
  Neoplastic disease Yes/No 
  Congestive heart failure Yes/No 
  Cerebrovascular disease Yes/No 
  Renal disease Yes/No 
  Liver disease Yes/No 
    
  If any "Yes," then proceed to Step 2  
  If all "No" then assign to Risk Class I  
    
Step 2: Stratify to Risk Class II vs. III vs. IV vs. V 
 Demographics 
Points 
Assigned 
  If Male +Age (yr) 
  If Female +Age (yr) – 10 
  Nursing home resident +10 
 Comorbidity 
  Neoplastic disease +30 
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  Liver disease +20 
  Congestive heart failure +10 
  Cerebrovascular disease +10 
  Renal disease +10 
 Physical Exam Findings 
  Altered mental status +20 
  Pulse ≥125/minute +10 
  Respiratory rate >30/minute +20 
  Systolic blood pressure <90 mm Hg +20 
  Temperature <35°C or ≥40°C +15 
 Lab and Radiographic Findings 
  Arterial pH <7.35 +30 
  
Blood urea nitrogen ≥30 mg/dl 
(9 mmol/liter) +20 
  Sodium <130 mmol/liter +20 
  Glucose ≥250 mg/dl (14 mmol/liter) +10 
  Hematocrit <30% +10 
  Partial pressure of arterial O2 <60mmHg +10 
  Pleural effusion +10 
    
  ∑ <70 = Risk Class II  
  ∑ 71-90 = Risk Class III  
  ∑ 91-130 = Risk Class IV  
  ∑ >130 = Risk Class V  
 
MATERIALS AND METHODS 
Study type: Retrospective clinical observational study 
Study Period: September 2014 to September 2015 
Source of data: Adult patients admitted to Department of Medicine who were diagnosed as 
community acquired pneumonia at admission. 
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Sample size: 50 patients 
Inclusion Criteria: 
● Age>12 years 
● Clinical symptoms like fever, cough with or without expectoration, pleuritic chest 
pain, dyspnea and altered sensorium. 
● Clinical Signs like tachypnea, reduced chest movements, dull percussion note, 
bronchial breath sounds, increased vocal fremitus and vocal resonance and 
crepitation. 
● Radiological evidence of pneumonia without any clinical evidence of pneumonia will 
also be included 
Exclusion criteria: 
● Hospital acquired pneumonia 
● Lung malignancy 
● Aspiration pneumonia 
● Pregnancy 
● PLWHA, neutropenic patients 
The method of Study: This is secondary data which was primarily collected in one of the 
hospitals in India. During the study period, all patients presenting with and fulfilling the 
inclusion criteria were included in this study. Detailed relevant history and clinical 
examination were done according to predesigned and pretested format (Annexure-1). All 
the patients were subjected to routine investigations like Complete blood count with ESR, 
Routine biochemistry (RBS, RFT, LFT, Electrolyte), Sputum for Gram stain, AFB, Sputum 
culture, Urine routine and microscopy, HIV, Chest X ray, Ultrasonography of Chest and 
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Abdomen, and HbA1c. Also, other investigation as necessary such as H1N1, Pneumopanel, 
Arterial blood gas analysis, and Blood culture. 
The diagnosis is made in each of these cases was noted down. The patients were 
classified according to PSI score classification. The patients were given a different group of 
antibiotics according to their general condition and had given supportive treatment 
according to their investigation. The primary outcome was defined as death. The secondary 
outcome was identified as O2 support, NIMV/IMV, Complication, Absence from work < 10 
days, and Absence from work > 10 days. 
The collected data was analyzed and compared with previous studies on same/similar 
topics. Statistical analysis wherever appropriate was applied. For the statistical analysis, 
tests like Chi Square test, Mean, Standard Deviation of Mean, Fischer Exact test, and Odds 
Ratio were used. 
OBSERVATIONS AND RESULTS 
In the present study, 50 patients of community acquired pneumonia were examined 
with an objective to study etiological profile, clinical and radiological profile and hospital 
outcome, the applicability of PSI score for the outcome, the outcome related to age, gender, 
and risk factors. In this study, the incidence of CAP was more common in female (56%) as 
compared to male (44%).The table 1 shows that the highest incidence of CAP was found in 
the age group 41-50 years (30%) followed by 51-60 years (18%) then followed by 31-40 
years. The Table 1 shows that age of 32 patients was below 50 years and age of 18 patients 
was above 50 years that was not statistically significant as p value is >0.05. In table 2, 34% 
patients have come under PSI class I, 28% patients have come under PSI class II, 18% 
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patients have come under PSI class III, 16% patients have come under PSI class IV, 4% 
patients have come under PSI class V. The table 3 shows that fever (94%) was the most 
common symptom followed by a cough (84%), and hemoptysis (6%) was the least common 
complaint by the participants. The table 3 shows that in young patients (age is <50 years) 
cough (87.5%) was the most common clinical feature followed by fever (78.1%) and 
breathlessness (71.8%) and among old patients (age is >50 years) fever (100%) was most 
common clinical features followed by a cough (77.7%) and breathlessness (72.2%).  
The table 4 shows that in male patients smoking (54%) was the most common risk 
factor and in female patients preceding URTI (28.5%) was the most common risk factor. 
Table 5 shows radiological findings in patients having different risk factors.  In the present 
study, lobar pneumonia was the most common in the patients having predisposing lung 
pathology (85.7%), and bronchopneumonia was most common in diabetic patients (71.4%). 
There was no statistical significance between risk factors (URTI, Smoker) for CAP and 
radiological findings as p value is >0.05 as per chi square test. The table 6 shows that 
bacterial pneumonia was occurred most commonly in patients having a risk factor of 
smoking (83.4%), preceding lung pathology (85.7%), alcohol (80%) and for H1N1 pneumonia, 
the most common risk factor was URTI (66.6%) followed by GERD (40%).  Chi square test 
was used for table 6 for URTI, DM, Lung pathology, and Smoking which shows there was 
statistical significance as p value is <0.05.  
The table 7 shows that 48% patients had bacteriological pneumonia, 38% patients 
had H1N1 pneumonia, 4% patients have fungal pneumonia. The table 7a shows bacterial 
pneumonia was more common in age < 50 years (66.6%) and H1N1 pneumonia was also 
more common in age < 50 years (78.9%). However, as per chi square test, this association 
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was not statistically significant as p value is >0.05. The table 7b shows that in 38% patients 
had H1N1 positive, 28% patients had pneumococci positive, in 10% patients no organism 
was identified. The table 8 shows that 75% patients with bacterial pneumonia had lobar 
involvement in chest x ray and 52.6% of H1N1 pneumonia had lobular involvement in chest 
x ray. The chi square test shows that this difference is statistically significant as p value is 
<0.05. In the present study, lobar pneumonia (54%) was the most common radiological 
feature on chest x ray. The table 9 indicates that 72.7% male and 75% female had required 
O2 support, 22.7% male and 14.2% female have required NIMV/IMV, 59.1% male and 50% 
female have developed a complication. This difference is not statistically significance as p 
value is >0.05. These results show that 77.7% of patients of age >50 years had required O2 
support, 33.3% of patients of >50 years had needed NIMV/IMV, 50% of patients with >50 
years had developed a complication. There is no statistically significant difference among 
above values as p value is >0.05. The table 9a shows that 66.6% bacterial pneumonia and 
78.9% H1N1 pneumonia had required O2 support, 8.33% bacterial pneumonia and 26.3% 
H1N1 pneumonia had required NIMV/IMV, 66.6% bacterial pneumonia and 57.8% H1N1 
pneumonia had developed a complication. This observation is statistically not significant as 
p value is >0.05. In this study, death had occurred in 8.33% bacterial pneumonia and 36.8% 
H1N1 pneumonia. This is statistically significant as p value is <0.05 by chi square test. The 
table 9b shows that 50% patients of class V had required O2 support and NIMV/IMV, 100% 
patients of class IV, had required O2 support and 50% patients had required 
NIMV/IMV,87.5% patients with class IV and 100% patients of class V had developed 
complication, 50% patients with class IV and class V had expired. This observation is 
statistically significant as p value is <0.05.  
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The table 10 shows that pleural effusion had occurred in 20.8% bacterial pneumonia 
and 5.26% H1N1 pneumonia. Respiratory failure had occurred in 12.5% bacterial pneumonia 
and 47.3% H1N1 pneumonia. The observation from the table 10 has statistically significant 
as p value is <0.05. The study shows that in expired male patients mean age is 57.75 years 
and in female was 44.2 years. The patients those who were expired due to bacterial 
pneumonia had mean age was 64 years and expired due to H1N1 pneumonia had mean age 
was 46.28 years. The respiratory failure (77.7%) was the most common complication in 
expired patients. Among expired patients’ bronchopneumonia was seen in 66.6% patients 
and lobar pneumonia was observed in 33.3% patients on chest x ray. The DM (33.3%) was 
the most common risk factors in expired patients.  
CONCLUSION AND DISCUSSION 
In the present study, it is found that H1N1 is a most common pathogen (38%) in CAP 
followed by Streptococcus pneumoniae (28%). In the study of Larry G Reimer, others and 
study of Sanraj K Basi Streptococcus were most common etiology. This study was done 
between September 2014 to September 2015 duration. In this period H1N1 epidemic 
occurred in our region. So, in this study H1N1 was the most common etiology in CAP 
patients. In the present study, the most common presenting complaint was fever followed 
by a cough followed by breathlessness. In Mac Fariene study, etiology and outcome of CAP, 
a cough was a most common presenting complaint (92%) followed by fever (86%) and then 
breathlessness (67%). 
Chest film showing infiltrates necessary to establish the diagnosis of pneumonia. 
Radiographic changes usually cannot be used to distinguish bacterial from nonbacterial 
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pneumonia, but they are often important for evaluating the severity of illness, determining 
the need for diagnostic studies and selecting an antibiotic agent. In the present study, most 
common chest x ray finding was patchy consolidation followed by left lower zone 
involvement and right lower zone involvement. 
PSI (pneumonia severity index) score is used for determination of hospital admission 
and assess 30-days mortality. Clinical trials demonstrate that routine use of the PSI score 
results in lower admission rates for a class I and class II patients. Patients in class III could 
ideally be admitted to an observation unit until a further decision can be made. In the 
present study, mortality was 50% in class IV and class V patients.  
PSI class 30-days mortality In hospital mortality in 
present study 
Class I 0.1% - 
Class II 0.6% 7.14% 
Class III 2.8% 33.3% 
Class IV 8.2% 50% 
Class V 29.2% 50% 
 
Implication for further research 
For the further study, more data will be needed to do and conclude the findings. This study only has 
50 participation which is one of the limitations of the study as well. Also, PSI score implementation 
for all patients who comes to the hospital with the clinical features of CAP which will give better data 
about PSI applicability and significance of PSI with the outcome. Also, observe and create a database 
on PSI score and respective treatment and then see what the outcome of the patients is. This 
implementation and suggestion will give a better dataset to reach a statistically significant 
conclusion about CAP. 
Prevention and other important points to tackle CAP 
Prevention of pneumonia involves either the decreasing likelihood of encountering 
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pathogen or Strengthening the host’s response once the pathogen is encountered or 
Immunization like Pneumococci vaccine. Also, early antibiotic administration within 4-6 
hours, empiric antibiotic treatment as per guidelines (IDSA / ATS), PORT – PSI scoring and 
Classification of cases, Early hospitalization in Class IV and V, Decrease smoking cessation - 
advice / counseling, Arterial oxygenation assessment in the first 24 hours, Blood culture 
collection in the first 24 h prior to another investigation, and Pneumococcal & Influenza 
vaccination. 
Results Tables 
TABLE 1. INCIDENCE BY AGE GROUP IN PATIENTS WITH CAP 
 AGE (In years)        MALE      FEMALE       TOTAL 
   No         No          No  
 <21 1(4.5%)  1(3.6%)  2(4%)  
 21-30 2(9%)  5(17.8%)  7(14%)  
<50 Years 31-40 2(9%) 12(40%) 6(21.4%) 20(24%) 8(16%)  
 41-50 7(31.8%)  8(28.6%)  15(30%)  
 51-60 3(13.6%)  6(21.4%)  9(18%)  
>50 Years 61-70 5(22.7%) 10(16%) 2(7.1%) 8(20%) 7(14%)  
 >70 2(9%)  0(0%)  2(4%)  
 TOTAL 22(56%)  28(44%)  50(100%)  
 Mean Age + SD 52+18  43+13  47+16  
 
TABLE 2. CLASSIFICATION OF PATIENTS ACCORDING TO PSI SEVERITY SCORE 
CLASS MALE(n=22) FEMALE(n=28) TOTAL(n=50) 
I 4(8.00%) 13(26.00%) 17(34%) 
II 5(10.00%) 9(18.00%) 14(28%) 
III 6(12.00%) 3(6.00%) 9(18%) 
IV 5(10.00%) 3(6.00%) 8(16%) 
V 2(4.00%) 0(0.00%) 2(4%) 
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TABLE 3. PRESENTATION OF CLINICAL FEATURES ACCORDING TO AGE AND GENDER 
Clinical Features Age Gender TOTAL(n=50) 
<50 Years >50 Years Male(n=22) Female(n=28) No  
Fever 29(90.6%) 18(100%) 21(95%) 26(92%) 47(94%)  
Cough 28(87.5%) 14(77.7%) 20(90%) 22(78%) 42(84%)  
Expectoration 13(40.6%) 9(50%) 11(50%) 11(39%) 22(44%)  
Breathlessness 22(68.7%) 14(77.7%) 17(77%) 19(67%) 36(72%)  
Pleuritic chest 
pain 
11(33.3%) 6(33.3% 7(31%) 10(35%) 17(34%)  
Hemoptysis 1(3.1%) 2(11.1%) 2(9%) 1(3%) 3(6%)  
Loss of weight 4(12.5%) 3(16.6%) 4(18%) 3(10%) 7(14%)  
 
TABLE 4. PRESENTATION OF RISK FACTOR IN CAP PATIENTS 
RISK FACTOR MALE(n=22) FEMALE(n=28) TOTAL(n=50) 
Preceding URTI 4(18.1%) 8(28.5%) 12(24%) 
DM 2(9%) 5(17.8%) 7(14%) 
Alcohol 5(22%) 0 5(10%) 
Lung pathology 7(32%) 0 7(14%) 
CHF 2(9%) 0 2(4%) 
Smoker 12(54%) 0 12(24%) 
Immunosuppressed 2(9%) 2(7.1%) 4(8%) 
TB 1(4.5%) 1(3.5%) 2(4%) 
GERD 1(4.5%) 4(14.2%) 5(10%) 
 
TABLE 5. COMPARISON BETWEEN RISK FACTORS AND RADIOLOGICAL FINDINGS 
CXR findings URTI(n=12) DM(n=7) Lung 
pathology(n=7) 
Smoker(n=12) GERD(n=5) 
Lobar 
involvement 
2(16.7%) 3(42.9%) 4(57.1%) 3(25%) 2(40%) 
Lobular 
involvement 
10(83.3%) 4(57.1) 3(42.9%) 9(75%) 3(60%) 
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TABLE 6. BACTERIAL VS H1N1 PNEUMONIA WITH VARIOUS RISK FACTORS 
Different CAP  URTI 
(n=12) 
DM 
(n=7) 
Lung 
pathology 
(n=7) 
Smoker 
(n=12) 
GERD 
(n=5) 
Alcohol 
(n=5) 
BACTERIAL 
PNEUMONIA  
4(33.3%) 5(71.4%) 6(85.7%) 10(83.4%) 3(60%) 4(80%) 
H1N1 PNEUMONIA 8(66.7%) 2(28.6%) 1(14.3%) 2(16.6%) 2(40%) 1(20%) 
TABLE 7. ETIOLOGICAL CLASSIFICATION OF CAP PATIENTS 
Etiology MALE(n=22) FEMALE(n=28) TOTAL(n=50) 
Bacteria 13(59%) 11(39.3%) 24(48%) 
H1N1 7(31.8%) 12(42.9%) 19(38%) 
Fungus 0 2(9%) 2(4%) 
Unidentified 2(9%) 3(10.7%) 5(10%) 
 
TABLE 7a. BACTERIAL VS H1N1 PNEUMONIA IN DIFFERENT AGE GROUP 
Age Group Bacterial pneumonia(n=24) H1N1 pneumonia (n=19) 
Age < 50 years 16 (66.6%) 15 (78.9%) 
Age > 50 years 8 (33.3%) 4 (21.1%) 
TABLE 7b. MICROORGANISM IDENTIFIED IN CAP PATIENTS 
ORGANISM NO OF PATIENTS(n=50) 
PNEUMOCOCCI 14(28%) 
STAPHYLOCOCCI 2(4%) 
MYCOPLASMA 1(2%) 
PSEUDOMONAS 2(4%) 
KLEBSIELLA 1(2%) 
AFB 4(8%) 
H1N1 19(38%) 
CANDIDA ALBICANS 2(4%) 
UNKNOWN ETIOLOGY 5(10%) 
TABLE 8. RADIOLOGICAL PROFILE IN BACTERIAL AND H1N1 PNEUMONIA 
RADIOLOGICAL PROFILE BACTERIAL PNEUMONIA 
(n=24) 
H1N1 PNEUMONIA 
(n=19) 
LOBAR PNEUMONIA 18(75%) 9(31.5%) 
BRONCHOPNEUMONIA 4(16.6%) 10(52.6%) 
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TABLE 9. SECONDARY OUTCOME OF CAP RELATED TO GENDER AND AGE 
SECONDARY 
OUTCOME 
MALE 
(n=22) 
FEMALE 
(n=28) 
Age < 50 
Years(n=32) 
Age > 50 
years(n=18) 
TOTAL(n=50
) 
O2 SUPPORT 17(77.2%) 21(75%) 24(75%) 14(77.7%) 38(76%) 
NIMV/IMV 5(22.7%) 4(14.2%) 3(9.3%) 6(33.3%) 9(18%) 
COMPLICATION 13(59.1%) 14(50%) 18(75%) 9(50%) 27(54%) 
ABSENCE FROM 
WORK  <10 DAYS 
10(45.5%) 23(82.1%) 23(71.8%) 10(55.5%) 33(66%) 
ABSENCE FROM 
WORK >10 DAYS 
3(13.6%) 5(17.8%) 5(15.6%) 3(16.6%) 8(16%) 
 
TABLE 9a. OUTCOME RELATED TO ETIOLOGY 
OUTCOME BACTERIAL 
PNEUMONIA(n=24) 
H1N1 
PNEUMONIA(n=19) 
O2 SUPPORT 16(66.6%) 15(78.9%) 
NIMV/IMV 2(8.33%) 5(26.3%) 
COMPLICATION 16(66.6%) 11(57.8%) 
ABSENCE FROM WORK  <10 DAYS 19(79.1%) 9(47.3%) 
ABSENCE FROM WORK >10 DAYS 3(12.5%) 3(15.7%) 
DEATH 2(8.33%) 7(36.8%) 
TABLE 9b. OUTCOME RELATED TO PSI CLASS 
 CLASS I 
(n=17) 
CLASS II 
(n=14) 
CLASS 
III(n=9) 
CLASS 
IV(n=8) 
CLASS V(n=2) 
O2 SUPPORT 10(58.8%) 12(85.7%) 7(77.7%) 8(100%) 1(50%) 
NIMV/IMV 0 0 4(57.1%) 4(50%) 1(50%) 
COMPLICATION 4(23.5%) 7(50%) 7(77.7%) 7(87.5%) 2(100%) 
ABSENCE FROM 
WORK  <10 DAYS 
14(77.7%) 11(78.6%) 8(88.9%) 7(87.5%) 2(100%) 
ABSENCE FROM 
WORK >10 DAYS 
3(17.6%) 3(21.4%) 1(11.1%) 1(12.5%) 0 
DEATH 0 1(7.14%) 3(33.3%) 4(50%) 1(50%) 
TABLE 10. DIFFERENT COMPLICATION IN CAP PATIENT 
COMPLICATION BACTERIAL 
PNEUMONIA (n=24) 
H1N1 PNEUMONIA 
(n=19) 
TOTAL(n=50) 
EMPYEMA 1(4.16%) - 1(2%) 
PLEURAL EFFUSION 5(20.8%) 1(5.26%) 8(16%) 
SEPTIC SHOCK 2(8.33%) 1(5.26%) 3(6%) 
SEPTIC AKI - - 1(2%) 
RESPIRATORY 
FAILURE 
3(12.5%) 9(47.3%) 13(26%) 
ARDS - 1(5.26%) 1(2%) 
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ANNEXURE I -ABBREVIATIONS 
AFB – Acid fast bacilli 
ARDS - Acute Respiratory Distress Syndrome 
BBS - Bronchial breath sound 
BP – Blood pressure 
COPD- Chronic obstructive pulmonary disease 
CAP - Community acquired pneumonia 
CRP - C-reactive protein 
CXR - Chest x-ray 
CHF – Congestive heart failure 
DM - Diabetes mellitus 
ECG – Electrocardiogram 
ESR – Erythrocyte sedimentation rate 
ELISA - Enzyme linked immunosorbent assay 
GERD - Gastro oesophageal reflux disease 
HIV- Human immune deficiency virus 
HR - Heart rate 
ICU - Intensive care unit 
IMV - Invasive mechanical ventilation 
LFT – Liver function test 
LRTI - Lower respiratory tract infection 
NIMV - Non-invasive mechanic ventilation 
PSI - Pneumonia severity index 
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RBS – Random blood sugar 
RFT- Renal function test 
RR - Respiratory rate 
TC - Total count 
URTI - Upper respiratory tract infection 
USG - Ultrasonography 
WBC – White blood cells 
ANNEXURE II – PROFORMA 
PROFORMA 
Irno.                                      Unit 
Name                                    DOA 
Age                                        DOD 
Occupation 
Address 
CHIEF COMPLAINTS: 
 Present/Absent Duration Others 
Fever    
Cough    
Expectoration    
Breathlessness    
Chest Pain    
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Haemoptysis    
Loss of Weight    
PREDISPOSING FACTORS: 
PRECEDING URTI ALLERGY 
DM PAST PNEUMONIA 
ALTERED SENSORIUM ASTHMA 
ALCOHOL TB 
COPD/ILD/BRONCHIACTASIS GERD 
CHF 
SMOKER 
IMMUNOCOMPROMISED 
FAMILY HISTORY: 
GENERAL EXAMINATION: 
BUILT, NOURISHMENT, TEMPERATURE, PULSE, B.P., RESPIRATORY RATE, PALLER, 
CYNOSIS, ICTERUS, CLUBBING, EDEMA, LYMPHADENOPATHY 
SYSTEMIC EXAMINATION: 
● RESPIRATORY SYSTEM: 
S/O Consolidation- 
S/O Effusion- 
S/O Obstructive Airway Disease- 
● CARDIOVASCULAR: 
● PER ABDOMEN: 
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● CNS: 
INVESTIGATIONS: 
HB, TC, HCT, PLT, FBS, PPBS, CREATININE, UREA, SODIUM, POTTASIUM, SPUTUM, 
GRAM STAIN, AFB, CULTURE, HBA1C, HIV, LFT, URINE, ALBUMIN, SUGAR, 
MICROSCOPY, CXR, ECG, 2DECHO, PNEUMOPANEL, H1N1, USG, CSF 
DIAGNOSIS: 
ADMISSION: 
ICU, WARD, Days of Absence from work  
TREATMENT: ANTIBIOTICS 
● Cephalosporin + Macrolide 
● Anti –Pseudomonal regimen 
● A + Fluoroquinolones 
● Other 
COMPLICATIONS: 
Septic shock, Endocarditis, Septic Encephalopathy, Respiratory Failure, Pleural 
effusion, Empyema 
CHEST X RAY: 
● LOBAR/BRONCHOPNEUMONIA 
● UL/BL 
● LATERAL VIEW 
RESULT: 
Survived/Expired        
